Genomic & Biopharma NewsStudy shines light on prevalence of hospital-acquired anemia
One in three patients hospitalized for medical problems experienced a drop in their red blood cell count due to the hospitalization – a concept called hospital-acquired anemia, new research showed.
|News Medical Life Sciences, 2017-05-18 13:56:14|
FDA expands approval for cystic fibrosis drug to treat additional rare gene mutations
The U.S. Food and Drug Administration today expanded the approved use of Kalydeco (ivacaftor) for treating cystic fibrosis.
|News Medical Life Sciences, 2017-05-18 13:49:03|
Teva, ditching a penchant for Israeli execs, taps out-of-towner as lead CEO pick: report
Teva’s getting close to snagging a new CEO, and this time, it’s not an Israeli citizen. Problem is, that fact could limit its CFO options.
|Fierce Pharma, 2017-05-18 13:44:25|
Roche builds case for T-cell bispecific-anti-PD-L1 combo
Roche has published early clinical data on its bispecific antibody in heavily pretreated patients with metastatic colorectal cancer. The readout hints that the T cell-activating antibody may improve outcomes in this hard-to-treat population when given as a monotherapy and in combination with anti-PD-L1 drug Tecentriq.
|Fierce Biotech, 2017-05-18 13:43:36|
Research findings may provide answers for infertility in older women
Findings from new research led by the Monash Biomedicine Discovery Institute and University College London may finally resolve, and potentially provide answers, as to why older women have higher incidences of miscarriage and have babies with chromosomal abnormalities.
|News Medical Life Sciences, 2017-05-18 13:30:00|
University of Warwick research focuses on absence epilepsy that affects children
A University of Warwick study to understand a form of epilepsy that affects children has received a grant from the charity Epilepsy Research UK. The research focuses on absence epilepsy which is largely a childhood condition which is characterized by sudden, brief interruptions of consciousness.
|News Medical Life Sciences, 2017-05-18 13:15:51|
Shire set to file for lanadelumab in hereditary angioedema
Shire's dominant position in the hereditary angioedema (HAE) market just firmed up with stellar data for its new candidate lanadelumab in the rare genetic disease class.
|Fierce Biotech, 2017-05-18 13:03:55|
A Coral to Outlast Climate Change
Stylophora pistillata, a reef coral in the Northern Red Sea, thrived in simulated global-warming conditions.
|The Scientist, 2017-05-18 13:00:00|
No such thing as “healthy obesity,” say experts
A new study from the University of Birmingham has presented evidence that could settle the debate over whether people can be obese and healthy at the same time.
|News Medical Life Sciences, 2017-05-18 12:56:29|